Immune Design’s quest for a cancer vaccine could go the distance By: MarketWatch August 25, 2017 at 13:38 PM EDT Developing a cancer vaccine is a tricky business, but Immune Design Corp.’s efforts could be the exception. Read More >> Related Stocks: Amgen Immune Design CS Standard & Poors 500 Valeant Pharmaceuticals International, Inc.